טוען...
Targeting the programmed cell death-1 pathway in rheumatoid arthritis
Since the introduction of TNF-α inhibitors and other biologic agents, the clinical outcome for many treated rheumatoid arthritis patients has significantly improved. However, there are still a substantial proportion of patients that are intolerant, or have inadequate responses, with current agents t...
שמור ב:
| הוצא לאור ב: | Autoimmun Rev |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596871/ https://ncbi.nlm.nih.gov/pubmed/28572054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.autrev.2017.05.025 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|